← Back to Clinical Trials
Recruiting NCT07206368

NCT07206368 Health Promotion With Targeted Exercise Intervention for Decreasing Fall Risk and Inactivity in Aging Veterans With Obesity and Signs of Sarcopenia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07206368
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Falls
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2030-05-01

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Fall prevention exerciseHealth promotion education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-04-01 with a primary completion date of 2030-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Falls are a major health risk for older Veterans, especially those with both obesity and low muscle mass or strength (sarcopenia), which together increase the chances of falling and losing independence. Many older Veterans have difficulty staying active and often lack information about how to safely exercise. While current guidelines focus mostly on weight loss, losing weight alone can weaken muscles and bones, which may actually raise the risk of falls and injuries. This study is testing the benefits of a virtual group exercise program combined with health education. The goal is to find out if exercise combined with health education is better at lowering fall risk and improving daily activity than health education alone for Veterans with obesity and signs of sarcopenia.

Eligibility Criteria

Inclusion Criteria: * Veteran status * 55 years or older * VA primary care provider * Enrolled in the VA Maryland Health Care System for health care * Body mass index between and including 30 - 40 kg/m\^2 * Showing signs of sarcopenia Exclusion Criteria: * Poorly controlled hypertensin * Home oxygen use * Contraindications to exercise or resistance exercise * Significant cognitive impairment * Other medical condition precluding patient participation in this study per the medical judgement of the study team

Contact & Investigator

Central Contact

Julie S Rekant, DPT PhD

✉ Julie.Rekant@va.gov

📞 (410) 605-7000

Principal Investigator

Julie S Rekant, DPT PhD

PRINCIPAL INVESTIGATOR

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Frequently Asked Questions

Who can join the NCT07206368 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Falls. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07206368 currently recruiting?

Yes, NCT07206368 is actively recruiting participants. Contact the research team at Julie.Rekant@va.gov for enrollment information.

Where is the NCT07206368 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT07206368 clinical trial?

NCT07206368 is sponsored by VA Office of Research and Development. The principal investigator is Julie S Rekant, DPT PhD at Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology